Navigating the Wild West of COVID-19 antibody tests
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
The expectation that widespread COVID-19 antibody testing will be a cornerstone for reopening society has prompted a speedy, hands-off regulatory approach. But reports of poor performance by marketed tests suggest moving too quickly could result in individual and public health decisions that are based on unreliable results.
Dodging that bullet will require centralized resources, including broad access to the large numbers of patient samples needed to stringently validate the assays...